On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Klinikum Braunschweig

InstitutionResearch output, impact & collaborations

Klinikum Braunschweig is a institution indexed in ScholarIQ from OpenAlex.

What is known about Klinikum Braunschweig?

ScholarIQrecord summary

Klinikum Braunschweig is a research organisation in Braunschweig, DE. OpenAlex records 2,348 works and 90,300 citations for it. 580 researchers list it as their most recent affiliation.

How many works does Klinikum Braunschweig have?

ScholarIQindexed works

Klinikum Braunschweig has 2,348 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Klinikum Braunschweig have?

ScholarIQcitation count

Klinikum Braunschweig has 90,300 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Klinikum Braunschweig?

ScholarIQresearcher count

Klinikum Braunschweig has 580 researchers in the ScholarIQ index.

What is the average h-index at Klinikum Braunschweig?

ScholarIQavg h-index

Klinikum Braunschweig has an average h-index of 64.5 in OpenAlex.

What is the ROR of Klinikum Braunschweig?

ScholarIQror

The ROR for Klinikum Braunschweig is on the source record.

What is the OpenAlex record for Klinikum Braunschweig?

ScholarIQopenalex

The OpenAlex for Klinikum Braunschweig is on the source record.

Who are the most-cited researchers behind Klinikum Braunschweig?

ScholarIQtop researchers by citations
1
Jan T. Kielstein · Acute Kidney Injury Research
482 works17,344 citations
2
Jürgen Krauter · Acute Myeloid Leukemia Research
254 works16,419 citations

What are the most-cited papers on Klinikum Braunschweig?

ScholarIQmost cited works
Serum uric acid and the risk of cardiovascular and renal disease
Claudio Borghi, Enrico Agabiti Rosei, Thomas Bardin, Jesse Dawson, Anna F. Dominiczak, Jan T. Kielstein, Athanasios Manolis, Fernando Pérez-Ruiz, Giuseppe Mancia
Journal of Hypertension. 2015467 Citations
Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
Gary R. Matzke, George R. Aronoff, Arthur J. Atkinson, William M. Bennett, Brian S. Decker, Kai‐Uwe Eckardt, Thomas A. Golper, Darren W. Grabe, Bertram L. Kasiske, Frieder Keller, Jan T. Kielstein, Ravindra L. Mehta, Bruce A. Mueller, Deborah A. Pasko, Franz Schaefer, Domenic A. Sica, Lesley A. Inker, Jason G. Umans, Patrick Murray
Kidney International. 2011458 CitationsOPEN ACCESS
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease
Claudio Borghi, Enrico Agabiti‐Rosei, Richard J. Johnson, Jan T. Kielstein, Empar Lurbe, Giuseppe Mancia, Josep Redón, Austin G. Stack, Konstantinos Tsioufis
European Journal of Internal Medicine. 2020424 CitationsOPEN ACCESS
Symmetrical Dimethylarginine
Stefanie M. Bode‐Böger, Fortunato Scalera, Jan T. Kielstein, Jens Martens‐Lobenhoffer, Gu[Combining Diaeresis]nter Breithardt, Manfred Fobker, Holger Reinecke
Journal of the American Society of Nephrology. 2006302 Citations
The EXTRIP (<i>EXtracorporeal TReatments In Poisoning</i>) workgroup: Guideline methodology
Valéry Lavergne, Thomas D. Nolin, Robert S. Hoffman, Darren M. Roberts, Sophie Gosselin, David S. Goldfarb, Jan T. Kielstein, Robert Mactier, Robert MacLaren, James B. Mowry, Timothy E. Bunchman, David N. Juurlink, Bruno Mégarbane, Kurt Anseeuw, James F. Winchester, Paul I. Dargan, Kathleen D. Liu, Lotte C. G. Hoegberg, Yi Li, Diane P. Calello, Emmanuel A. Burdmann, Chris Yates, Martin Laliberté, Brian S. Decker, Carlos Augusto Mello-da-Silva, Eric J. Lavonas, Marc Ghannoum
Clinical Toxicology. 2012136 CitationsOPEN ACCESS

How much of the research on Klinikum Braunschweig is open access?

ScholarIQopen access share
60%OPEN ACCESS
Gold
0%
Green
20%
Hybrid
20%
Bronze
20%
Closed
40%

Related on ScholarIQ

470M+ articles · 14-day free trial